Kennedy Pushes FDA to Reclassify Peptide Drugs
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- Kennedy told Joe Rogan in February he expects FDA action within weeks to reclassify around 14 peptide drugs so compounding pharmacies can offer them again, reversing a 2023 Biden rule; he called himself "a big fan of peptides" and said he'd "used them myself to really good effect on a couple of injuries."
- Researchers including UC Davis cell biologist Paul Knoepfler warn that cancer risk from growth hormone peptides may not surface for 3-5 years; the startup Finnrick found 30% of tested peptides were mislabeled, under- or overdosed, or contaminated with toxins or bacteria.
- Wellness influencers Joe Rogan, Stanford neurobiologist Andrew Huberman, biohacker Gary Brecka, and Gwyneth Paltrow have helped mainstream peptides, while the popular "Wolverine stack" of BPC-157 and TB-500 was banned by the U.S. Anti-Doping Agency in 2022.
- Two women were hospitalized in critical condition after peptide injections at a Las Vegas longevity conference in 2024, according to ProPublica; regulators couldn't determine whether the peptides themselves or contamination caused the illness.
- Imports of hormone and peptide compounds from China doubled in the first three quarters of 2025 to $328 million, per the New York Times, fueling gray- and black-market supply.
- Lewis Grossman, a health law professor at American University, frames the peptide embrace not as anti-science but as medical libertarianism — the same "right to try" philosophy that drives pushback against vaccine mandates, echoing the 1970s backlash against vitamin regulation.
Why it matters: Kennedy's push would reverse a 2023 Biden rule and reopen compounding-pharmacy access to roughly 14 drugs that researchers say carry unstudied cancer risks and a 30% contamination rate per independent testing. The peptide stance reveals a consistent libertarian thread in MAHA politics — physical autonomy over therapeutic choice — rather than a contradiction with his vaccine-skepticism demands for more research.
